Trial Profile
A double-blind parallel-group 4-week trial to assess the efficacy and safety of etoricoxib 60mg and diclofenac 150mg in patients with chronic low back pain.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary) ; Diclofenac
- Indications Back pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Organon
- 25 Oct 2005 New trial record.